HDAC3 and p300 are critical epigenetic regulators that are implicated in the pathophysiology of ischemic stroke.[44] In this study, we demonstrated that enhancing MeCP2 lactylation via HDAC3 inhibition or p300 activation significantly mitigated ischemic brain injury and improved neurological outcomes. This evidence concerns the gene MECP2 and ischemic stroke.